(19)
(11) EP 1 613 346 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
09.01.2013 Bulletin 2013/02

(45) Mention of the grant of the patent:
28.11.2012 Bulletin 2012/48

(21) Application number: 04722345.8

(22) Date of filing: 22.03.2004
(51) International Patent Classification (IPC): 
A61K 39/39(2006.01)
(86) International application number:
PCT/IB2004/000937
(87) International publication number:
WO 2004/087204 (14.10.2004 Gazette 2004/42)

(54)

MICROFLUIDIZED OIL-IN-WATER EMULSIONS AND VACCINE COMPOSITIONS

MIKROFLUIDISIERTE ÖL-IN-WASSER-EMULSIONEN UND VAKZINEZUSAMMENSETZUNGEN

EMULSIONS MICROFLUIDIFIEES D'HUILE DANS L'EAU ET COMPOSITIONS DE VACCINS

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

(30) Priority: 04.04.2003 US 460301 P

(43) Date of publication of application:
11.01.2006 Bulletin 2006/02

(73) Proprietor: PAH USA 15 LLC
New York, NY 10017-5755 (US)

(72) Inventors:
  • DOMINOWSKI, Paul J., Pfizer Global Research & Dev.
    Kalamazoo, MI 49001 (US)
  • KLOSE, Pamela Kay, Pfizer Global Research and Dev.
    Groton, CT 06340 (US)
  • KREBS, Richard Lee, Pfizer Global Research and Dev
    Lincoln, Nebraska 68521 (US)
  • MANNAN, Ramasamy M., Pfizer Global Research & Dev.
    Kalamazoo, MI 49001 (US)

(74) Representative: Pfizer 
European Patent Department 23-25 avenue du Docteur Lannelongue
75668 Paris Cedex 14
75668 Paris Cedex 14 (FR)


(56) References cited: : 
EP-A- 1 023 904
US-A- 5 961 970
US-B1- 6 306 405
 WO-A-93/24147
US-B1- 6 274 149
US-B1- 6 451 325
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).